Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Niowave
AddedFeb 15, 2024
UpdatedJun 18, 2026
Niowave

Niowave

Niowave, based in Lansing, US, is a domestic provider of medical and industrial radioisotopes.

HQ
Lansing, MI, US
Founded
2005
Overview
Compare
Fundraising
Employees
Website

Niowave, founded in Lansing, US, is dedicated to the production of medical and industrial radioisotopes. Their core mission is to manufacture radioisotopes that cure cancer and save lives. Utilizing a superconducting linear accelerator (linac) instead of a nuclear reactor, Niowave offers a range of alpha, beta, and gamma sources from uranium and radium. Their innovative approach not only enhances safety but also ensures a reliable domestic supply of critical isotopes for medical and industrial applications.

Notable figures associated with Niowave include its founders and key investors who have supported the company's pioneering technology. The company has achieved significant milestones, including establishing a robust inventory of radioisotopes and contributing to advancements in cancer treatment. Niowave's impact is profound, providing essential materials that support life-saving medical procedures and industrial processes, thereby reinforcing their vision of improving health outcomes and advancing scientific progress.

Niowave - Similar Companies

Northwest Medical Isotopes logo

Northwest Medical Isotopes

Alpha Source logo

Alpha Source

alphasource.com

NorthStar Medical Radioisotopes logo

NorthStar Medical Radioisotopes

Arizona Isotope Science Research logo

Arizona Isotope Science Research

azisotopes.org

Atomic Alchemy logo

Atomic Alchemy

Nu Planet Pharmaceutical Radioisotopes logo

Nu Planet Pharmaceutical Radioisotopes

nuplanet.tech

Nucleus RadioPharma logo

Nucleus RadioPharma

nucleusrad.com

Vivos logo

Vivos

radiogel.com

Shine Medical Technologies logo

Shine Medical Technologies

shinefusion.com

Ion Linac Systems logo

Ion Linac Systems

ionlinacs.com

Ionetix logo

Ionetix

ionetix.com

Coqui Radio Pharmaceuticals logo

Coqui Radio Pharmaceuticals

Radiomedix logo

Radiomedix

radiomedix.com

RadioRx logo

RadioRx

radiorx.com

Xetawave logo

Xetawave

xetawave.com

Niowave - Quick Facts

Who are Niowave's competitors?

Companies similar to Niowave include Northwest Medical Isotopes, Alpha Source, NorthStar Medical Radioisotopes and Arizona Isotope Science Research.

When was Niowave founded?

Niowave was founded in 2005.

Where is Niowave's headquarters located?

Niowave's headquarters is located in Lansing, MI, US.

When was Niowave's last funding round?

Niowave's most recent funding round was for $500k (USD) in April 2023.

How much has Niowave raised to-date?

As of Apr 11, 2023, Niowave has raised a total of $5.2M (USD).

How many employees does Niowave have?

Niowave has 101 employees as of Feb 5, 2024.

Niowave - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Model
  • Manufacturing
Revenue
  • Recurring
Customer
  • Enterprise
  • Government
Main Product
  • Radioisotopes
Tags
  • Biotech
  • Medical
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 2790Manufacture of other electrical equipment
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 335900Other Electrical Equipment and Component Manufacturing
  • 335990All Other Electrical Equipment and Component Manufacturing
  • 335999All Other Miscellaneous Electrical Equipment and Component Manufacturing
  • 330000Manufacturing
  • 325000Chemical Manufacturing
  • 335000Electrical Equipment, Appliance, and Component Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 3690Miscellaneous Electrical Machinery, Equipment, And Supplies
  • 3699Electrical Machinery, Equipment, And Supplies, Not Elsewhere Classified
  • 2800Chemicals And Allied Products
  • 3600Electronic And Other Electrical Equipment And Components, Except Computer
  • 2830Drugs
  • 2834Pharmaceutical Preparations